Associated Papers
Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
Annuar AA et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2021
Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
Zhang M et al.
Cancer Medicine, 2016
Association between FAS and FASL genetic variants and risk of primary brain tumor.
Dalan AB et al.
The International Journal of Neuroscience, 2014
Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians.
Karimi MY et al.
Cancer Investigation, 2013
Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
Sun Z et al.
Connective Tissue Research, 2013
Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W et al.
Plos One, 2013
FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.
Zhong-Xing Z et al.
Plos One, 2013
Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.
Tong N et al.
Leukemia & Lymphoma, 2012
A Fas gene polymorphism influences herpes simplex virus type 2 infection in South African women.
Chatterjee K et al.
Journal of Medical Virology, 2010
Select a paper to view details